Key result
Study evaluates QUANTEC guidelines for predicting cardiac mortality risk following breast cancer radiotherapy.
Why the study?
Cardiac mortality in breast cancer patients treated with radiotherapy has been addressed and prompted changes in clinical practice, motivating evaluation of QUANTEC guidelines to predict cardiac mortality risk.
Do QUANTEC guidelines accurately predict the risk of cardiac mortality in breast cancer patients treated with radiotherapy?
Do QUANTEC guidelines accurately predict the risk of cardiac mortality in breast cancer patients treated with radiotherapy?
This study evaluates the clinical utility of QUANTEC guidelines in predicting cardiac mortality among breast cancer patients receiving radiotherapy.
Answers are grounded in this paper and cite their sources.
QUANTEC guidelines' predictive accuracy for cardiac mortality remains uncertain in this cohort; leaves open the need for updated validation before clinical adoption.
Cardiac mortality in breast cancer patients treated with radiotherapy (RT) has been addressed in the literature and prompted changes in clinical practice [1]. The Quantitative Analysis of Normal Ti...
No takes yet. Share an insight, caveat, or question.
Moiseenko et al. (2016) studied this question. QUANTEC guidelines were evaluated for their ability to predict cardiac mortality risk in breast cancer patients treated with radiotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: